National Institute for Innovation in Manufacturing Biopharmaceuticals

Sartorius is an active member of the NIIMBL, the National Institute for Innovation in Manufacturing Biopharmaceuticals, headquartered in Newark, Delaware, USA. The Institute, launched in 2017, is a public-private partnership and has an extensive network of academic and industry partners within the U.S. Among the 115 associated members are 71 academic institutions, research laboratories, non-profit organizations and 44 companies – ranging from start-ups, small, medium and large companies. Besides, NIIMBL also engages several federal agencies. NIIMBL’s multi-pronged mission includes the following: accelerate biopharmaceutical manufacturing innovations, support the development of standards, enable more efficient and rapid manufacturing capabilities and establish an international, leading workforce to fundamentally strengthen the U.S. biopharmaceutical industry.

Recently NIIMBL expanded its membership offerings, allowing technology providers wider access to participation. Sartorius joined the organization through this new affiliate membership program that permits the company to actively support the NIIMBL community activities. Furthermore, the program allows Sartorius to influence the organization’s portfolio of existing innovation projects, give feedback to the review of new project proposals and directly sponsor one of the upcoming projects.

Sartorius is participating in multiple NIIMBL technology projects and contributing to define the structure of new NIIMBL-led initiatives for optimizing and accelerating the current manufacturing processes in the biopharmaceutical industry.